[3] [4] PCOS, GLP-1 Treatment and Menstrual Changes Polycystic ovary syndrome (PCOS) affects approximately 10% of women of reproductive age in the UK and is characterised by irregular periods, elevated androgens, and often insulin resistance
Semaglutide has a terminal half-life of approximately 1 week (about 7 days or 168 hours), according to FDA prescribing information
Intentional fueling becomes essential
But their use introduces several major risks that require early planning and constant, proactive vigilance to manage
The drugs also warn about side effects like pancreatitis, diabetic retinopathy, low blood sugar, kidney problems, allergic reactions and sudden gallbladder disease
These are all naturally occurring hormones that play a big role in regulating blood sugar, appetite, and metabolism